L-dopa in Parkinsonism. A possible mechanism of action.
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism*; D001921:Brain / Q000187:drug effects*; D002247:Carbon Isotopes; D002540:Cerebral Cortex / Q000378:metabolism*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy*; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014316:Tritium; D014443:Tyrosine / Q000378:metabolism; D014508:Urea / Q000378:metabolism
D000588:Amines; D002247:Carbon Isotopes; D006892:Hydroxydopamines; D014316:Tritium; D012701:Serotonin; D014443:Tyrosine; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D014508:Urea; D004298:Dopamine; D009638:Norepinephrine